MC5R
Basic information
Region (hg38): 18:13824149-13827323
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MC5R gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 1 | 1 |
Variants in MC5R
This is a list of pathogenic ClinVar variants found in the MC5R region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-13826110-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
18-13826140-C-T | Benign (May 21, 2018) | |||
18-13826177-G-C | not specified | Uncertain significance (Jan 04, 2024) | ||
18-13826189-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
18-13826228-A-G | not specified | Uncertain significance (Jun 28, 2022) | ||
18-13826236-G-C | not specified | Uncertain significance (Nov 03, 2023) | ||
18-13826276-A-T | not specified | Uncertain significance (Feb 27, 2024) | ||
18-13826277-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
18-13826277-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
18-13826316-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
18-13826351-G-A | not specified | Likely benign (Sep 27, 2022) | ||
18-13826417-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
18-13826498-G-T | not specified | Uncertain significance (Aug 21, 2023) | ||
18-13826514-G-T | not specified | Uncertain significance (Feb 27, 2023) | ||
18-13826571-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
18-13826574-G-C | not specified | Uncertain significance (Sep 29, 2022) | ||
18-13826622-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
18-13826622-G-T | not specified | Uncertain significance (Oct 06, 2021) | ||
18-13826648-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
18-13826717-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
18-13826733-G-C | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MC5R | protein_coding | protein_coding | ENST00000324750 | 1 | 2708 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000651 | 0.298 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0722 | 202 | 205 | 0.986 | 0.0000134 | 2159 |
Missense in Polyphen | 64 | 67.923 | 0.94224 | 811 | ||
Synonymous | -0.101 | 83 | 81.8 | 1.01 | 0.00000589 | 663 |
Loss of Function | -0.209 | 6 | 5.47 | 1.10 | 2.36e-7 | 70 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for MSH (alpha, beta and gamma) and ACTH. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. This receptor is a possible mediator of the immunomodulation properties of melanocortins.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- loftool
- 0.690
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.74
Haploinsufficiency Scores
- pHI
- 0.135
- hipred
- N
- hipred_score
- 0.333
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.606
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mc5r
- Phenotype
- vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-activating G protein-coupled receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- melanocortin receptor activity;protein binding;hormone binding